Shares Bazaar

Lupin Ltd.   (BSE: LUPIN)

NSE   0.00  
OPEN PRICE(₹)
0.00
HIGH PRICE(₹)
0.00
LOW PRICE(₹)
0.00
CLOSE PRICE(₹)
0.00
VOLUME
0.00
52 WK LOW (₹)
828.4 (27-07-2020)
52 WK HIGH (₹)
1267.65 (02-06-2021)
BSE   648.45  
OPEN PRICE₹)
663.25
HIGH PRICE(₹)
667.15
LOW PRICE (₹)
646.15
CLOSE PRICE(₹)
648.45
VOLUME
17996
VALUE
11669500
BID QTY
0
OFFER QTY
0

Stock Summary

Trade Value (₹ in Lacs) : 907.19 MCap (₹ in Mn) : 476390.5 Dividend Yield(%) : 0.57 Price/Earning (TTM) : 54.89
TTM EPS (₹) : 0 Price/Sales (TTM) : 0 P/E Ratio : 0.01 Price/Book (MRQ) : 2.65
Book Value(₹) : 0 Face Value(₹) : 0 Latest Reserve (₹ in Mn): 178988.1 EPSc : 16.06
PE : 65.39 TTMNP : 8678.3 TTMTAX : 3796.3 TTMINTEREST : 481
TTMDEPRECIATION : 5077.3 TTMNetSales : 107319.4 EV_Sales : 4.32 EV (in Mn) : 463389.5
TTMEBITDA : 21833.2 EV_EBITDA : 21.22 TTMCashProfit : 13755.6 TTMCEPS : 30.33
Price_CEPS : 34.63 TTMNPAEX : 8678.3

Peer Group Compare

Comp. Name Price M.Cap Div Yld % P/E Ratio Price/Earning (TTM) TTM EPS (₹)
Sun Pharmaceutical Industries Ltd. (BSE)

920.8 ( 1.53%)

135418.47 0.71 0 47 12.01
Divis Laboratories Ltd. (BSE)

3641.9 ( 1.71%)

91003.96 0.47 0.06 51.76 66.23
Dr. Reddys Laboratories Ltd. (BSE)

4139.5 ( -1.04%)

81092.78 0.51 0.04 33.02 147.67
Cipla Ltd. (BSE)

1067.8 ( 0.57%)

67867.68 0.48 0.01 30.26 27.81
Aurobindo Pharma Ltd. (BSE)

517.45 ( -0.59%)

55333.11 0.32 0.01 20.8 45.4

Management Info

Chairman : Manju D Gupta
Managing Director : Nilesh Gupta
Company Secretory : R V Satam
Incorporation Year : 1983

Registered Office

Address : Kalpataru Inspire, 3rd Floor
Off. Western Express Highway
Santacruz (East)
City-Pincode : Mumbai-400055
Phone : 022 6640 2323
Website : www.lupinworld.com
Email : info@lupinworld.com

Registrars Details

Registrars Details : Link Intime India Pvt Ltd.
Address : C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra
Listing : BSE, NSE, MCX

Balance Sheet

(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
SOURCES OF FUNDS:
Share Capital 0.91 0.91 0.9 0.9 0.9
  Equity - Authorised 2 2 2 2 2
  Equity - Issued 0.91 0.91 0.9 0.9 0.9
 Equity Paid Up 0.91 0.91 0.9 0.9 0.9
  Equity Shares Forfeited 0.00 0.00 0.00 0.00 0.00
  Adjustments to Equity 0.00 0.00 0.00 0.00 0.00
  Preference Capital Paid Up 0 0 0 0 0
  Face Value 0 0 0 0 0
Share Warrants & Outstandings 0.00 0.00 0.00 0.00 0.00
Total Reserves 122.31 134.33 132.75 132.34 109.59
  Securities Premium 9.18 8.64 8.13 7.55 6.78
  Capital Reserves 0.26 0.26 0.25 0.25 0.25
  Profit & Loss Account Balances 102.3 108.84 105.5 107.07 85.58
  General Reserves 16.77 16.67 16.6 16.56 16.54
Reserve excluding Revaluation Reserve 122.31 134.33 132.75 132.34 109.59
Revaluation Reserves 0 0 0 0 0
Deposits 0.00 0.00 0.00 0.00 0.00
  Demand Deposits 0.00 0.00 0.00 0.00 0.00
  Savings Deposit 0.00 0.00 0.00 0.00 0.00
  Term Deposits / Fixed Deposits 0.00 0.00 0.00 0.00 0.00
  Current Deposits 0.00 0.00 0.00 0.00 0.00
  Recurring Deposits 0.00 0.00 0.00 0.00 0.00
  Other Deposits 0.00 0.00 0.00 0.00 0.00
Borrowings 0.00 0.00 0.00 0.00 0.00
  Borrowings From Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Banks 0.00 0.00 0.00 0.00 0.00
  Borrowings From GOI 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Financial Institutions 0.00 0.00 0.00 0.00 0.00
  Borrowings in the form of Bonds / Debentures 0.00 0.00 0.00 0.00 0.00
  Borrowings in Other Form 0.00 0.00 0.00 0.00 0.00
Other Liabilities & Provisions 0.00 0.00 0.00 0.00 0.00
  Bills Payable 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Liabilities 0.00 0.00 0.00 0.00 0.00
  Interest Accrued 0.00 0.00 0.00 0.00 0.00
  Proposed Dividend 0.00 0.00 0.00 0.00 0.00
  Corporate dividend tax payable 0.00 0.00 0.00 0.00 0.00
  Other Liabilities & Provisions 2.96 3.71 3.57 3.09 1.9
Total Liabilities 155.59 215.31 209.24 200.92 172.37
APPLICATION OF FUNDS :
Cash and balance with Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Cash with RBI 0.00 0.00 0.00 0.00 0.00
  Cash in hand & others 0.00 0.00 0.00 0.00 0.00
Balances with banks and money at call 0.00 0.00 0.00 0.00 0.00
Investments 28.57 27.45 6.54 30.95 9.84
Investments in India 0.00 0.00 0.00 0.00 0.00
  GOI/State Govt. Securities 0.00 0.00 0.00 0.00 0.00
  Equity Shares - Corporate 0.00 0.00 0.00 0.00 0.00
  Debentures & Bonds 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures/Associates 0.00 0.00 0.00 0.00 0.00
  Units - MF/ Insurance/CP/PTC 0.00 0.00 0.00 0.00 0.00
Investments outside India 0.00 0.00 0.00 0.00 0.00
  Government securitiesC 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures abroad 0.00 0.00 0.00 0.00 0.00
  Other investments outside India 0.00 0.00 0.00 0.00 0.00
  Less: Prov for Diminution in Value of Invest. 0.00 0.00 0.00 0.00 0.00
Advances 0.00 0.00 0.00 0.00 0.00
  Bills Purchased & Discounted 0.00 0.00 0.00 0.00 0.00
  Cash Credit, Over Draft & Loans repayable 0.00 0.00 0.00 0.00 0.00
  Term Loans 0.00 0.00 0.00 0.00 0.00
  Finance lease and hire purchase receivable 0.00 0.00 0.00 0.00 0.00
Gross block 141.61 157.32 138.6 123.95 92.12
  Premises 21.79 21.61 16.47 15.78 9.22
  Assets Given on Lease 0.00 0.00 0.00 0.00 0.00
  Other Fixed Assets 0.00 0.00 0.00 0.00 0.00
Less: Accumulated Depreciation 62.22 46.45 34.98 13.62 4.95
Net Block 79.38 110.87 103.62 110.33 87.17
Less: Impairment of Assets 0.00 0.00 0.00 0.00 0.00
Lease Adjustment 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 9.4 16.4 25.98 21.33 27.02
Other Assets 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Assets 0.00 0.00 0.00 0.00 0.00
  Interest Accrued Assets 0.00 0.00 0.00 0.00 0.00
  Tax paid in advance/TDS 0.00 0.00 0.00 0.00 0.00
  Stationery and stamps 0.00 0.00 0.00 0.00 0.00
  Non-banking assets acquired 0.00 0.00 0.00 0.00 0.00
  Deferred tax asset 0.00 0.00 0.00 0.00 0.00
  Miscellaneous Expenditure not written off 0.00 0.00 0.00 0.00 0.00
Total Assets 155.59 215.31 209.24 200.92 172.37
Contingent Liabilities 3.25 7.96 6.86 6.64 7.34
  Claims not acknowledged as debts 3.25 7.96 6.86 6.64 7.34
  Outstanding forward exchange contracts 0.00 0.00 0.00 0.00 0.00
  Guarantees given in India 0.00 0.00 0.00 0.00 0.00
  Guarantees given Outside India 0.00 0.00 0.00 0.00 0.00
  Acceptances, endorsements & other obligations 0.00 0.00 0.00 0.00 0.00
Bills for collection 0.00 0.00 0.00 0.00 0.00
Book Value 0.27 0.3 0.3 0.3 0.25
Adjusted Book Value 0.27 0.3 0.3 0.3 0.25
(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
SOURCES OF FUNDS:
Share Capital 0.91 0.91 0.9 0.9 0.9
  Equity - Authorised 2 2 2 2 2
  Equity - Issued 0.91 0.91 0.9 0.9 0.9
 Equity Paid Up 0.91 0.91 0.9 0.9 0.9
  Equity Shares Forfeited 0.00 0.00 0.00 0.00 0.00
  Adjustments to Equity 0.00 0.00 0.00 0.00 0.00
  Preference Capital Paid Up 0.00 0.00 0.00 0.00 0.00
  Face Value 0 0 0 0 0
Share Warrants & Outstandings 0.00 0.00 0.00 0.00 0.00
Total Reserves 171.68 168.08 154.83 145.16 117.09
  Securities Premium 9.18 8.64 8.13 7.55 6.78
  Capital Reserves 0.26 0.26 0.26 0.26 0.25
  Profit & Loss Account Balances 145.93 142.27 129.61 120.24 92.9
  General Reserves 16.77 16.67 16.6 16.56 16.54
Reserve excluding Revaluation Reserve 171.68 168.08 154.83 145.16 117.09
Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
Deposits 0.00 0.00 0.00 0.00 0.00
  Demand Deposits 0.00 0.00 0.00 0.00 0.00
  Savings Deposit 0.00 0.00 0.00 0.00 0.00
  Term Deposits / Fixed Deposits 0.00 0.00 0.00 0.00 0.00
  Current Deposits 0.00 0.00 0.00 0.00 0.00
  Recurring Deposits 0.00 0.00 0.00 0.00 0.00
  Other Deposits 0.00 0.00 0.00 0.00 0.00
Borrowings 0.00 0.00 0.00 0.00 0.00
  Borrowings From Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Banks 0.00 0.00 0.00 0.00 0.00
  Borrowings From GOI 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Financial Institutions 0.00 0.00 0.00 0.00 0.00
  Borrowings in the form of Bonds / Debentures 0.00 0.00 0.00 0.00 0.00
  Borrowings in Other Form 0.00 0.00 0.00 0.00 0.00
Other Liabilities & Provisions 0.00 0.00 0.00 0.00 0.00
  Bills Payable 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Liabilities 0.00 0.00 0.00 0.00 0.00
  Interest Accrued 0.00 0.00 0.00 0.00 0.00
  Proposed Dividend 0.00 0.00 0.00 0.00 0.00
  Corporate dividend tax payable 0.00 0.00 0.00 0.00 0.00
  Other Liabilities & Provisions 2.73 2.09 2.06 1.68 1.22
Total Liabilities 179.32 174.27 160.86 150.72 121.54
APPLICATION OF FUNDS :
Cash and balance with Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Cash with RBI 0.00 0.00 0.00 0.00 0.00
  Cash in hand & others 0.00 0.00 0.00 0.00 0.00
Balances with banks and money at call 0.00 0.00 0.00 0.00 0.00
Investments 78.36 77.41 56.84 72.16 40.1
Investments in India 0.00 0.00 0.00 0.00 0.00
  GOI/State Govt. Securities 0.00 0.00 0.00 0.00 0.00
  Equity Shares - Corporate 0.00 0.00 0.00 0.00 0.00
  Debentures & Bonds 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures/Associates 0.00 0.00 0.00 0.00 0.00
  Units - MF/ Insurance/CP/PTC 0.00 0.00 0.00 0.00 0.00
Investments outside India 0.00 0.00 0.00 0.00 0.00
  Government securitiesC 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures abroad 0.00 0.00 0.00 0.00 0.00
  Other investments outside India 0.00 0.00 0.00 0.00 0.00
  Less: Prov for Diminution in Value of Invest. 0.00 0.00 0.00 0.00 0.00
Advances 0.00 0.00 0.00 0.00 0.00
  Bills Purchased & Discounted 0.00 0.00 0.00 0.00 0.00
  Cash Credit, Over Draft & Loans repayable 0.00 0.00 0.00 0.00 0.00
  Term Loans 0.00 0.00 0.00 0.00 0.00
  Finance lease and hire purchase receivable 0.00 0.00 0.00 0.00 0.00
Gross block 56.66 48.08 43.73 36.69 26.49
  Premises 15.7 13.37 11.57 11.03 7.49
  Assets Given on Lease 0.00 0.00 0.00 0.00 0.00
  Other Fixed Assets 0.00 0.00 0.00 0.00 0.00
Less: Accumulated Depreciation 21.52 14.35 10.32 6.57 3.04
Net Block 35.14 33.73 33.41 30.13 23.45
Less: Impairment of Assets 0 0 0 0 0
Lease Adjustment 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 8.22 11.99 11.71 4.81 6.24
Other Assets 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Assets 0.00 0.00 0.00 0.00 0.00
  Interest Accrued Assets 0.00 0.00 0.00 0.00 0.00
  Tax paid in advance/TDS 0.00 0.00 0.00 0.00 0.00
  Stationery and stamps 0.00 0.00 0.00 0.00 0.00
  Non-banking assets acquired 0.00 0.00 0.00 0.00 0.00
  Deferred tax asset 0.00 0.00 0.00 0.00 0.00
  Miscellaneous Expenditure not written off 0.00 0.00 0.00 0.00 0.00
Total Assets 179.32 174.27 160.86 150.72 121.54
Contingent Liabilities 65.6 84.36 77.15 68.42 63.96
  Claims not acknowledged as debts 3.25 3.05 2.34 68.42 63.96
  Outstanding forward exchange contracts 0.00 0.00 0.00 0.00 0.00
  Guarantees given in India 0.00 0.00 0.00 0.00 0.00
  Guarantees given Outside India 0.00 0.00 0.00 0.00 0.00
  Acceptances, endorsements & other obligations 0.00 0.00 0.00 0.00 0.00
Bills for collection 0.00 0.00 0.00 0.00 0.00
Book Value 0.38 0.37 0.34 0.32 0.26
Adjusted Book Value 0.38 0.37 0.34 0.32 0.26

Quarterly Results

Particulars Sep-2020 Jun-2020 Mar-2020 Feb-2019
Date End Audited Audited Audited Audited
Interest Earned 38350.00 35278.60 38457.40 37692.70
Income On Investments 0.00 0.00 0.00 0.00
Interest On Balances With Rbi Other Inter Bank Funds 0.00 0.00 0.00 0.00
Interest / Discount On Advances / Bills 0 0 0 0
Others 0 0 0 0
Other Income 249.6 432.8 2086 935.9
Total Income 38599.6 35711.4 40543.4 38628.6
Interest Expended 336.2 442.6 1073.8 886
Operating Expenses 0 0 0 0
Total Expenditure 32538.3 30397.8 33204.2 33401.7
Operating Profit Before Provisions and Contingencies 6061.3 5313.6 7339.2 5226.9
Exceptional Items 0 0 830.9 -2886.8
Provisions and contingencies 0 0 0 0
Profit Before Tax 3597.8 2724.6 4953.7 -1078.2
Tax 1467 1643.2 1050.7 7670.2
Profit After Tax 2130.8 1081.4 3903 -8748.4
+/- Extraordinary Items 0 0 0 0
+/- Prior period items 0 0 0 0
Net Profit 2130.8 1081.4 3903 -8413.6
Minority Interest -24.9 -18 -16.6 53.6
Shares of Associates 4.3 5.6 9.9 10
Other related items 0 0 0 0
Misc. Expenses Written off 0.00 0.00 0.00 0.00
Consolidated Net Profit 2130.8 1081.4 3903 -8413.6
Equity Capital 2110.2 1069 3896.3 -8350
Face Value (IN RS) 2 2 2 2
Reserves 0 0 0 0
% of Shares held by Govt 0 0 0 0
Capital Adequacy Ratio 0.00 0.00 0.00 0.00
Gross / Net NPAs 0.00 0.00 0.00 0.00
Amount of Gross NPAs 0.00 0.00 0.00 0.00
Amount of Net NPAs 0 0 0 0
% of Gross / Net NPAs NA NA NA NA
% of Net NPAs 0 0 0 0
% of Gross NPAs 0 0 0 0
Return on Assets 0 0 0 0
No of Public Share Holdings NA NA NA NA
% of Public Share Holdings NA NA NA NA
Basic Eps After Extraordinary Items 4.71 2.4 8.64 -19.3
Basic Eps Before Extraordinary Items 4.71 2.4 8.64 -19.3
PBIDTM% 15.81 15.06 19.08 13.87
PBDTM% 14.93 13.81 18.45 3.86
PBTM% 9.38 7.72 12.88 -2.86
PATM% 5.56 3.07 10.15 -23.21
Particulars Sep-2020 Jun-2020 Mar-2020
Date End Audited Audited Audited
Interest Earned 30426.0 26950.8 24838.8
Income On Investments 0 0 0
Interest On Balances With Rbi Other Inter Bank Funds 0 0 0
Interest / Discount On Advances / Bills 0 0 0
Others 0.00 0.00 0.00
Other Income 252.9 340.1 2099.1
Total Income 30678.9 27290.9 26937.9
Interest Expended 91.3 86.8 113.8
Operating Expenses 0.00 0.00 0.00
Total Expenditure 24448.2 20997.8 22484.7
Operating Profit Before Provisions and Contingencies 6230.7 6293.1 4453.2
Exceptional Items 0 0 0
Provisions and contingencies 0.00 0.00 0.00
Profit Before Tax 4883.4 4954.9 3091.6
Tax 1279.1 1319.1 838.7
Profit After Tax 3604.3 3635.8 2252.9
+/- Extraordinary Items 0.00 0.00 0.00
+/- Prior period items 0.00 0.00 0.00
Net Profit 3604.3 3635.8 2252.9
Minority Interest 0.00 0.00 0.00
Shares of Associates 0.00 0.00 0.00
Other related items 0.00 0.00 0.00
Misc. Expenses Written off 0.00 0.00 0.00
Consolidated Net Profit 3604.3 3635.8 2252.9
Equity Capital 3604.3 3635.8 2252.9
Face Value (IN RS) 2 2 2
Reserves 0 0 0
% of Shares held by Govt 0.00 0.00 0.00
Capital Adequacy Ratio 0.00 0.00 0.00
Gross / Net NPAs 0.00 0.00 0.00
Amount of Gross NPAs 0.00 0.00 0.00
Amount of Net NPAs 0.00 0.00 0.00
% of Gross / Net NPAs NA NA NA
% of Net NPAs 0.00 0.00 0.00
% of Gross NPAs 0.00 0.00 0.00
Return on Assets 0.00 0.00 0.00
No of Public Share Holdings NA NA NA
% of Public Share Holdings NA NA NA
Basic Eps After Extraordinary Items 7.95 8.03 4.98
Basic Eps Before Extraordinary Items 7.95 8.03 4.98
PBIDTM% 20.48 23.35 17.93
PBDTM% 20.18 23.03 17.47
PBTM% 16.05 18.39 12.45
PATM% 11.85 13.49 9.07

Profit-Loss

-
Particulars
-
Particulars

Financial Ratios

Particulars
Particulars

Cash Flow

(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Net Profit Before Taxes 8.77 15.17 5.47 35.43 33.29
Adjustments for Expenses & Provisions : 15.74 15.88 27.82 12.15 5.85
Adjustments for Liabilities & Assets: -4.71 -5 -10.19 5.05 -31.26
Refund/(payment) of direct taxes -5.11 -9.39 -5.58 -11.49 -11.7
Other Direct payments 0 0 0 0 0
Cash Flow from operating activities 14.69 16.66 17.51 41.14 -3.82
Cash Flow from investing activities 11.07 -32.82 4.7 -25.27 -69.62
Cash Flow from financing activities -8.91 7.44 -14.92 4.33 58.36
Effect of exchange fluctuation on translation reserve 0 0 0 0 0
Net increase/(decrease) in cash and cash equivalents 16.85 -8.72 7.29 20.19 -15.08
Opening Cash & Cash Equivalents 5.44 14.16 6.87 7.8 20.95
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 1.93
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0 0 0 0 0
Closing Cash & Cash Equivalent 22.29 5.44 14.16 27.99 7.8
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 1.93
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0 0 0 0 0
(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Net Profit Before Taxes 8.77 15.17 5.47 35.43 33.29
Adjustments for Expenses & Provisions : 15.74 15.88 27.82 12.15 5.85
Adjustments for Liabilities & Assets: -4.71 -5 -10.19 5.05 -31.26
Refund/(payment) of direct taxes -5.11 -9.39 -5.58 -11.49 -11.7
Other Direct payments 0 0 0 0 0
Cash Flow from operating activities 14.69 16.66 17.51 41.14 -3.82
Cash Flow from investing activities 11.07 -32.82 4.7 -25.27 -69.62
Cash Flow from financing activities -8.91 7.44 -14.92 4.33 58.36
Effect of exchange fluctuation on translation reserve 0 0 0 0 0
Net increase/(decrease) in cash and cash equivalents 16.85 -8.72 7.29 20.19 -15.08
Opening Cash & Cash Equivalents 5.44 14.16 6.87 7.8 20.95
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 1.93
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0 0 0 0 0
Closing Cash & Cash Equivalent 22.29 5.44 14.16 27.99 7.8
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 1.93
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0 0 0 0 0

Share Price

Year Open Price (₹) High Price (₹) Low Price (₹) Close Price (₹) Volume (000's) Value (in Lakhs)
February-2021 1005.35 1086.95 978.15 1052.45 1068.04 11173.04
January-2021 979 1113.55 975.5 1007.75 3354.02 35159.1
December-2020 896 992.85 875 977.3 3214.32 30600.93
November-2020 910 962.95 856 891.8 3313.35 29932.29
October-2020 1029.7 1087.65 906.05 908.4 2047.7 20813.39
September-2020 928 1121.85 909.9 1007.1 3060.68 30678.18
August-2020 930 1034.55 874.9 927.55 4517.54 43825.56
Lupin gets nod from USFDA for Diclofenac Sodium Topical Solution USP, 2% w/w22-Sep-2022 03:44 PM  
Lupin surges on receiving Health Canada's approval for Rymti13-Sep-2022 02:52 PM  
Lupin receives Health Canada's approval for Rymti13-Sep-2022 02:45 PM  
Lupin informs about press release09-Sep-2022 01:01 PM  
Lupin rises on launching generic Suprep Bowel Prep Kit in United States09-Sep-2022 12:17 PM  
Lupin launches generic Suprep Bowel Prep Kit in United States09-Sep-2022 12:08 PM  
Lupin informs about press release07-Sep-2022 05:16 PM  
Lupin surges on inking agreement with DKSH to market five Biosimilar candidates in Philippines07-Sep-2022 02:35 PM  
Lupin, DKSH ink agreement to market five Biosimilar candidates in Philippines07-Sep-2022 12:05 PM  
Lupin’s arm recalls 7,872 bottles of Rifampin Capsules in US market05-Sep-2022 10:52 AM  
Lupin gains on getting tentative approval from USFDA for Dasatinib Tablets30-Aug-2022 11:07 AM  
Lupin gets tentative approval from USFDA for Dasatinib Tablets29-Aug-2022 04:20 PM  
Lupin rises on launching Desvenlafaxine Extended-Release Tablets in United States29-Aug-2022 11:52 AM  
Lupin launches Desvenlafaxine Extended-Release Tablets in United States26-Aug-2022 05:59 PM  
Lupin informs about press release26-Aug-2022 04:25 PM